Anonymous
Guest
Anonymous
Guest
Will this be NPCs lifesaver? Doubt it. Any thoughts?
@above poster...
does not sound to promising...why do you say sales will suck? I know its an orphan drug...but you don't think this will turn into something big?
Inflammatory disease team being built. These are specialty positions, so comp same as onc or xolair. Phase III data just released, looks very strong. External Analysts calling it a blockbuster. Strong leadership team. I'd bet on this drug and team. Great opportunity if you want to build your own business, own your own territory, and have a lot more opportunity to think than primary care. I hear there are a lot of reps posting for each territory, so must be something to it.
Maybe comp ties to progressions, not sure. But these are definitely Specialty positions, not primary care.
Maybe comp ties to progressions, not sure. But these are definitely Specialty positions, not primary care.
It might work in GOUT
BUT - if anyone in management tells you to mention that fact to doctors....document, document.....as you might have a whistleblower case.....it will be an OFF Label promotion.
The key to Ilaris will be an RA indication. Without it, it may end up being another Fanapt. Its a good security move for GM reps or NeuroPsych. If RA indication comes its a game changer. GA is just the beginning.